Marcia Belvin

12.7k total citations · 5 hit papers
74 papers, 6.9k citations indexed

About

Marcia Belvin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marcia Belvin has authored 74 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 27 papers in Oncology and 15 papers in Immunology. Recurrent topics in Marcia Belvin's work include PI3K/AKT/mTOR signaling in cancer (21 papers), Melanoma and MAPK Pathways (19 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Marcia Belvin is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (21 papers), Melanoma and MAPK Pathways (19 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Marcia Belvin collaborates with scholars based in United States, France and United Kingdom. Marcia Belvin's co-authors include Kathryn V. Anderson, Lori S. Friedman, Dominique Ferrandon, Vanessa Gobert, Marie Gottar, Jules A. Hoffmann, Julien Royet, Klaus P. Hoeflich, Geoffrey M. Duyk and Jean‐Marc Reichhart and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marcia Belvin

74 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway

1996 666 citations Marcia Belvin, Kathryn V. Anderson profile →
The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein

2002 554 citations Marcia Belvin, Geoffrey M. Duyk et al. profile →
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

2016 527 citations Bryan Irving, Marcia Belvin et al. Immunity profile →
Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors

2006 357 citations Marcia Belvin, Jules A. Hoffmann et al. Cell profile →
A genome-wide analysis of immune responses in Drosophila

2001 328 citations Marcia Belvin, Casey Kopczynski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcia Belvin United States	37	3.3k	2.8k	2.0k	1.3k	724	74	6.9k
Pascal Meier United Kingdom	44	5.7k 1.8×	2.6k 0.9×	1.2k 0.6×	506 0.4×	441 0.6×	80	8.0k
Y. Tony Ip United States	47	4.9k 1.5×	3.0k 1.1×	732 0.4×	1.4k 1.1×	1.6k 2.2×	81	8.3k
Nicholas F. Totty United Kingdom	43	7.9k 2.4×	1.8k 0.6×	1.9k 1.0×	198 0.2×	804 1.1×	66	11.3k
Vineeta Agarwala United States	10	10.0k 3.0×	1.0k 0.4×	976 0.5×	378 0.3×	440 0.6×	18	12.0k
Michael Gilman United States	43	6.5k 2.0×	1.6k 0.6×	2.0k 1.0×	170 0.1×	682 0.9×	68	9.1k
Ophir Shalem United States	21	11.6k 3.5×	830 0.3×	1.1k 0.6×	507 0.4×	470 0.6×	42	13.1k
Andreas Bergmann United States	41	3.9k 1.2×	1.6k 0.5×	572 0.3×	267 0.2×	742 1.0×	94	5.6k
Jacques Camonis France	58	8.9k 2.7×	1.7k 0.6×	1.7k 0.9×	137 0.1×	690 1.0×	149	11.9k
Erika A Bach United States	29	2.0k 0.6×	2.9k 1.0×	2.0k 1.0×	172 0.1×	541 0.7×	48	5.1k
Matthias Gstaiger Switzerland	40	4.5k 1.4×	875 0.3×	1.1k 0.6×	162 0.1×	213 0.3×	72	6.4k

Countries citing papers authored by Marcia Belvin

Since Specialization

Citations

This map shows the geographic impact of Marcia Belvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia Belvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia Belvin more than expected).

Fields of papers citing papers by Marcia Belvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia Belvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia Belvin. The network helps show where Marcia Belvin may publish in the future.

Co-authorship network of co-authors of Marcia Belvin

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia Belvin. A scholar is included among the top collaborators of Marcia Belvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia Belvin. Marcia Belvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boustany, Leila M., Sherry L. LaPorte, Joel Shen, et al.. (2022). A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity. Cancer Research. 82(22). 4288–4298. 35 indexed citations

Berezhnoy, Alexey, Hsin Wang, Na Cai, et al.. (2022). 1078 Conditionally activatable interferon-alpha 2b improves tolerability and exhibits preferential activity in tumors. Regular and Young Investigator Award Abstracts. A1120–A1120. 1 indexed citations

Shen, Joel, Jing Cao, Vangipuram S. Rangan, et al.. (2020). CX-2043, an EpCAM-targeting probody drug conjugate, demonstrates anti-tumor activity with a favorable safety profile in preclinical models. European Journal of Cancer. 138. S15–S15. 4 indexed citations

Dogan, Taner, Florian Gnad, Jocelyn Chan, et al.. (2017). Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. Journal of Biological Chemistry. 292(35). 14311–14324. 19 indexed citations

Wong, Harvey, Laurent Vernillet, Amy Peterson, et al.. (2012). Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor. Clinical Cancer Research. 18(11). 3090–3099. 65 indexed citations

Hatzivassiliou, Georgia, Bonnie Liu, Carol O’Brien, et al.. (2012). ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors. Molecular Cancer Therapeutics. 11(5). 1143–1154. 155 indexed citations

Wallin, Jeffrey J., Jane Guan, Wei Wei Prior, et al.. (2012). GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo. Clinical Cancer Research. 18(14). 3901–3911. 73 indexed citations

McCleland, Mark L., Adam S. Adler, Yonglei Shang, et al.. (2012). An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer. Cancer Research. 72(22). 5812–5823. 150 indexed citations

Choo, Edna F., Chee M. Ng, Leanne Berry, et al.. (2012). PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts. Cancer Chemotherapy and Pharmacology. 71(1). 133–143. 26 indexed citations

10.

Choo, Edna F., Marcia Belvin, Jason Boggs, et al.. (2012). Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions. Drug Metabolism and Disposition. 40(5). 919–927. 28 indexed citations

11.

Hoeflich, Klaus P., Mark Merchant, Christine Orr, et al.. (2011). Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition. Cancer Research. 72(1). 210–219. 200 indexed citations

12.

Edgar, Kyle A., Jeffrey J. Wallin, Megan Berry, et al.. (2010). Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors. Cancer Research. 70(3). 1164–1172. 94 indexed citations

13.

Belvin, Marcia, Leanne Berry, Julie Chan, et al.. (2010). 132 Intermittent dosing of the MEK inhibitor, GDC-0973, and the PI3K inhibitor, GDC-0941, results in prolonged accumulation of Bim and causes strong tumor growth inhibition in vivo. European Journal of Cancer Supplements. 8(7). 48–48. 4 indexed citations

14.

Hoeflich, Klaus P., Sylvia Herter, Janet Tien, et al.. (2009). Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression. Cancer Research. 69(7). 3042–3051. 144 indexed citations

15.

Hoeflich, Klaus P., Carol O’Brien, Zachary Boyd, et al.. (2009). In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models. Clinical Cancer Research. 15(14). 4649–4664. 385 indexed citations

16.

Wallin, Jeffrey J., Kyle A. Edgar, Jane Guan, Lori S. Friedman, & Marcia Belvin. (2009). Abstract #3392: Transient pAkt increase after chemo exposure predicts strength of synergy for combinations of the PI3K inhibitor GDC-0941 and chemotherapeutics. Cancer Research. 69. 3392–3392. 1 indexed citations

17.

Yao, Evelyn, Wei Zhou, Si Tuen Lee-Hoeflich, et al.. (2009). Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab. Clinical Cancer Research. 15(12). 4147–4156. 104 indexed citations

18.

Naitza, Silvia, Carine Rossé, Christine Kappler, et al.. (2002). The Drosophila Immune Defense against Gram-Negative Infection Requires the Death Protein dFADD. Immunity. 17(5). 575–581. 126 indexed citations

19.

Ollmann, Michael, Lynn Young, Charles J. Di Como, et al.. (2000). Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53. Cell. 101(1). 91–101. 336 indexed citations

20.

Belvin, Marcia, Yishi Jin, & Kathryn V. Anderson. (1995). Cactus protein degradation mediates Drosophila dorsal-ventral signaling.. Genes & Development. 9(7). 783–793. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact